Eye health professionals are always focusing on the prevention of eye diseases; ensuring that patients avoid losing their sight is of the highest priority. Age-related macular degeneration (AMD) is a condition which usually damages the sight of older adults, but…
Winner announced! Who won the thrilling supercar experience courtesy of Elektron Technology and Topcon at Optrafair 2013? Congratulations to Bonita Irish from Hallcroft Opticians in Shepshed who is the winner of a free trial of the MPS II macular pigment screener…
Over 300 optometrists tested the new portable MPS II macular pigment scanner on the Topcon stand at Optrafair 2013. The event comes ahead of the announcement of the AREDS 2 trial next month which is widely expected to produce more evidence for…
‘Macular testing improved my practice, both commercially and clinically’ In this month’s Optometry Today, optometrist Scott Mackie talks about the benefits that MPS II has brought to his two practices in Scotland. Six months ago, he acquired the macular pigment screening…
MPS II is a screening device which helps eyecare professionals spot the signs of age-related macular degeneration in their patients. There are immediate benefits in installing the device in the practice, both for the patient and for the clinicians themselves.…
New research published this week has linked cholesterol levels to sight loss – showing that simple eye drops could be used to treat the UK’s biggest cause of blindness, age-related macular degeneration (AMD). Although the research is in its early…
Age-related macular degeneration is a debilitating disease which can lead to loss of sight. What’s the difference between the two types – wet and dry – and how can the new screening device MPS II help delay and even prevent…